FOXO4-DRI
The Senolytic Cell Clearing Peptide
A groundbreaking senolytic peptide that selectively eliminates senescent 'zombie' cells, potentially reversing aspects of aging.
Research Compound
About FOXO4-DRI
FOXO4-DRI is a revolutionary senolytic peptide that selectively induces apoptosis (programmed cell death) in senescent cells—often called 'zombie cells' because they no longer divide but refuse to die. These cells accumulate with age and secrete inflammatory factors that damage surrounding tissue (the SASP—Senescence-Associated Secretory Phenotype). By clearing these cells, FOXO4-DRI may restore tissue function and reverse aspects of aging. Early research in mice showed remarkable rejuvenation of fur, kidney function, and overall vitality.
Mechanism of Action
FOXO4-DRI is a modified peptide that disrupts the interaction between FOXO4 and p53 in senescent cells. Normally, FOXO4 sequesters p53 in the nucleus, preventing senescent cells from undergoing apoptosis. FOXO4-DRI blocks this interaction, freeing p53 to trigger programmed cell death specifically in senescent cells while leaving healthy cells unaffected. This selective targeting is what makes FOXO4-DRI such a promising anti-aging intervention.
How FOXO4-DRI Works in Your Body:
- Target Receptors: FOXO4-DRI binds to specific receptors that trigger downstream signaling cascades related to its primary benefits.
- Physiological Response: The body responds by modulating natural processes—whether hormone release, tissue repair, or cellular signaling—without replacing endogenous function.
- Timeline: Effects typically begin within 1-2 weeks, with optimal results seen over the recommended protocol duration.
Dosing Protocol
Frequency
2-3 times per week
Timing
Any time of day
Duration
2-4 week cycles, repeated as needed
Important Notes
Dosing is experimental; typical protocols use 5-10mg via subcutaneous or IV injection. Due to its potent effects, medical supervision is strongly recommended. Very expensive due to complex synthesis.
Clinical Research
3 studies on FOXO4-DRI
Senescent Cell Clearance
FOXO4-DRI selectively eliminated senescent cells in aged mice, restoring fitness, fur density, and renal function.
Cell
Mechanism Study
FOXO4-DRI disrupts the FOXO4-p53 axis specifically in senescent cells, triggering apoptosis.
Cell
Healthspan Extension
Treatment improved multiple markers of healthspan in naturally aged and chemotherapy-treated mice.
Cell
Important Safety Information
Medical Disclaimer: The information provided about FOXO4-DRI is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or peptide protocol.
Research Status: While FOXO4-DRI has shown promising results in research studies, many peptides are still being studied and may not be approved by regulatory bodies like the FDA for specific uses. The research cited represents ongoing scientific investigation.
Individual Variation: Responses to peptides vary significantly between individuals. What works for one person may not work for another. Side effects, while generally mild, can occur and should be monitored closely.
Quality & Sourcing: If you choose to use peptides, ensure you obtain them from reputable, tested sources. Peptide quality, purity, and proper storage are critical for safety and efficacy.
Legal Considerations: Peptide regulations vary by country and jurisdiction. Some peptides may require a prescription or may have restrictions on their use. Research the laws in your area before obtaining or using peptides.